Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 6 of about 6   

Articles published

NVS 80.14 +0.23 (0.29%)
price chart
Novartis Sues Sun Over Proposed Generic Zometa, Reclast
Swiss drugmaker Novartis AG sued Sun Pharmaceutical Industries Ltd. to block it from selling generic forms of the bone-strengthening medications Zometa and Reclast.
New pharmacovigilance system debuts in EU
New rules governing the monitoring, identification and assessment of adverse events caused by pharmaceuticals are introduced, with the aim of making the EU-wide system for overseeing drug safety and 'benefit-risk' more transparent and robust.
FXI's Not The Best China ETF
Matt Hougan, our president of ETF Analytics, was on CNBC's Fast Money recently and talked about the pitfalls of the iShares FTSE China 25 Index Fund (NYSEArca:FXI) and why other funds like the SPDR S&P China ETF (NYSEArca:GXC) might be a better ...
Investment basics: why stock volume matters. A lot
Volume = liquidity, and liquidity makes it easy to get into and out of positions. There's no arena more important when it comes to stock volume in emerging markets.
Four Korean technology stocks to watch
However, the American ADR has very little liquidity. Look for other Korean stocks that are a little closer to home. LG DISPLAY COMPANY ( LPL , quote ): The LG Group is another powerful force in Korean technology stocks.
POSCO-SS VINA in Vietnam - Analyst Blog
aiming to benefit from the growing South East Asian markets, recently laid the foundation of POSCO SS-VINA in Vietnam through its operating unit, POSCO Specialty Steel .
POSCO-SS VINA in Vietnam